Autopsy report · NCT00125606

Phase 3 Trial for AML Patients in CR2 Comparing 8Gy TBI /Fludarabine to Conditioning With TBI 12Gy/Cyclophosphamide

“insufficient patient recruitement”

The sponsor’s own words in the registry.

Life of this trial

• Registered 9 months after it had already started.
• Ran for about 6 years 9 months before it stopped.
• 30 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

University Hospital Muenster

Sponsor type

University, hospital or other

Conditions

Acute Myeloid Leukemia

Interventions

conditioning for allogeneic HSCT

Participants

30

Sites

1

Countries

Germany

Trials that died the same way

• Daptomycin in Pediatric Patients With Bacterial Meningitis
  “Insufficient patient recruitment” (90% match in meaning)
• The CEASE Study: Computer Based Educational Module for the Reduction of Arthralgia Syndrome Associated With Endocrine Therapy for Breast Cancer
  “Unable to recruit sufficient patients” (89% match in meaning)
• Project 4A: Inspiratory Muscle Training and Diaphragm Strength
  “Unable to recruit sufficient number of patients” (87% match in meaning)
• Phosphodiesterase (PDE) Inhibitors Effect on Cognitive Deficits Associated to Schizophrenia
  “Patient recruitment insufficient” (86% match in meaning)
• Individualization Treatment Through a Self-managed Web-based Solution in Ulcerative Colitis
  “not able to recruit patients” (86% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.